Logo image
Novel gRNA design pipeline to develop broad-spectrum CRISPR/Cas9 gRNAs for safe targeting of the HIV-1 quasispecies in patients
Journal article   Open access   Peer reviewed

Novel gRNA design pipeline to develop broad-spectrum CRISPR/Cas9 gRNAs for safe targeting of the HIV-1 quasispecies in patients

Neil T Sullivan, Will Dampier, Cheng-Han Chung, Alexander G Allen, Andrew Atkins, Vanessa Pirrone, Greg Homan, Shendra Passic, Jean Williams, Wen Zhong, …
Scientific reports, v 9(1), pp 17088-19
19 Nov 2019
PMID: 31745112
url
https://doi.org/10.1038/s41598-019-52353-9View
Published, Version of Record (VoR)CC BY V4.0 Open

Abstract

Cohort Studies Computational Biology CRISPR-Cas Systems Female Gene Editing Genome, Viral HIV Infections - genetics HIV Infections - virology HIV Long Terminal Repeat - genetics HIV-1 - genetics HIV-1 - growth & development HIV-1 - metabolism Humans Male Middle Aged Proviruses - genetics Quasispecies - genetics RNA, Guide - genetics
The CRISPR/Cas9 system has been proposed as a cure strategy for HIV. However, few published guide RNAs (gRNAs) are predicted to cleave the majority of HIV-1 viral quasispecies (vQS) observed within and among patients. We report the design of a novel pipeline to identify gRNAs that target HIV across a large number of infected individuals. Next generation sequencing (NGS) of LTRs from 269 HIV-1-infected samples in the Drexel CARES Cohort was used to select gRNAs with predicted broad-spectrum activity. In silico, D-LTR-P4-227913 (package of the top 4 gRNAs) accounted for all detectable genetic variation within the vQS of the 269 samples and the Los Alamos National Laboratory HIV database. In silico secondary structure analyses from NGS indicated extensive TAR stem-loop malformations predicted to inactivate proviral transcription, which was confirmed by reduced viral gene expression in TZM-bl or P4R5 cells. Similarly, a high sensitivity in vitro CRISPR/Cas9 cleavage assay showed that the top-ranked gRNA was the most effective at cleaving patient-derived HIV-1 LTRs from five patients. Furthermore, the D-LTR-P4-227913 was predicted to cleave a median of 96.1% of patient-derived sequences from other HIV subtypes. These results demonstrate that the gRNAs possess broad-spectrum cutting activity and could contribute to an HIV cure.

Metrics

13 Record Views
25 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Multidisciplinary Sciences
Logo image